Predictive in vitro primary proximal tubule models for understanding nephrotoxicity in drug development programs

4pm (GMT) 27th February 2020

Up to 60% of animal studies fail to identify subsequent drug-to-drug interactions or toxicity in man. Find out how the properties of in vitro proximal tubule epithelial cell (PTEC) models can be used to understand the renal handling of drug molecules and de-risk adverse reactions in drug development programs. Colin will present several case studies illustrating the use of aProximateâ„¢ PTEC human and animal models with small molecules and biologics. He will demonstrate the value of measuring biomarkers of toxicity, providing mechanistic and species-specific data about the transport of molecules, and predicting potential nephrotoxicity of new drug molecules.

Your details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)




Dr Colin Brown
Director of Admet Technology
Newcells Biotech
View Biography